XBiotech (XBIT) Revenue & Revenue Breakdown

XBiotech Revenue Highlights

Main Segment (Y)

Manufacturing Revenue

XBiotech Revenue by Period

XBiotech Revenue by Year

Date	Revenue	Change
2023-12-31	-	-100.00%
2022-12-31	$4.01M	-78.20%
2021-12-31	$18.39M	-58.19%
2020-12-31	$44.00M	100.00%
2019-12-31	-	100.00%
2018-12-31	-	100.00%
2017-12-31	-	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	-

XBiotech generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

XBiotech Revenue by Quarter

Date	Revenue	Change
2024-09-30	-	100.00%
2024-06-30	-	100.00%
2024-03-31	-	-100.00%
2023-12-31	$2.62M	100.00%
2023-09-30	-	100.00%
2023-06-30	-	100.00%
2023-03-31	-	-100.00%
2022-12-31	$300.00K	-82.14%
2022-09-30	$1.68M	9.80%
2022-06-30	$1.53M	206.00%
2022-03-31	$500.00K	-88.89%
2021-12-31	$4.50M	-0.42%
2021-09-30	$4.52M	-0.13%
2021-06-30	$4.53M	-6.70%
2021-03-31	$4.85M	-7.95%
2020-12-31	$5.27M	-50.05%
2020-09-30	$10.55M	-31.93%
2020-06-30	$15.50M	22.21%
2020-03-31	$12.68M	100.00%
2019-12-31	-	100.00%
2019-09-30	-	100.00%
2019-06-30	-	100.00%
2019-03-31	-	100.00%
2018-12-31	-	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	100.00%
2017-12-31	-	100.00%
2017-11-02	-	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	-

XBiotech generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

XBiotech Revenue Breakdown

XBiotech Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22	Dec 21	Dec 20
Clinical Trial Service Revenue	-	$394.00K	$25.98M
Manufacturing Revenue	$4.01M	$18.00M	$18.00M
Product and Service, Other	-	-	$22.00K

XBiotech's latest annual revenue breakdown by segment (product or service), as of Dec 22: Manufacturing Revenue (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Manufacturing Revenue	$300.00K	$1.68M	$1.53M	$500.00K	$4.50M	$4.50M	$4.50M	$4.50M	$4.50M	$6.00M	$4.50M	$3.00M
Clinical Trial Service Revenue	-	-	-	-	-	$19.00K	$25.00K	$350.00K	$747.00K	$4.55M	$11.00M	$9.68M

XBiotech's latest quarterly revenue breakdown by segment (product or service), as of Dec 22: Manufacturing Revenue (100.00%).

XBiotech Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Manufacturing Revenue	$300.00K	$1.68M	$1.53M	$500.00K	$4.50M	$4.50M	$4.50M	$4.50M	$4.50M	$6.00M	$4.50M	$3.00M
Clinical Trial Service Revenue	-	-	-	-	-	$19.00K	$25.00K	$350.00K	$747.00K	$4.55M	$11.00M	$9.68M

XBiotech's latest quarterly revenue breakdown by geography, as of Dec 22: Manufacturing Revenue (100.00%).

XBiotech Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TSVT	2seventy bio	$100.39M	$13.53M
VECT	VectivBio	$27.34M	$676.00K
STOK	Stoke Therapeutics	$8.78M	$4.89M
KZR	Kezar Life Sciences	$7.00M	-
KRON	Kronos Bio	$6.29M	$2.37M
GBIO	Generation Bio	$5.90M	$4.09M
ABSI	Absci	$5.72M	$898.00K
PHAT	Phathom Pharmaceuticals	$682.00K	$16.35M
CCCC	C4 Therapeutics	-	-
XFOR	X4 Pharmaceuticals	-	$560.00K
DAWN	Day One Biopharmaceuticals	-	$20.07M
ABOS	Acumen Pharmaceuticals	-	-
INZY	Inozyme Pharma	-	-
REPL	Replimune Group	-	-
ERAS	Erasca	-	-
XBIT	XBiotech	-	-
PASG	Passage Bio	-	-
ADVM	Adverum Bio	-	-
ONCT	Oncternal Therapeutics	-	-
EWTX	Edgewise Therapeutics	-	-
ELDN	Eledon Pharmaceuticals	-	-

XBIT Revenue FAQ

What is XBiotech’s yearly revenue?

XBiotech's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $4.01M, representing a decrease of -78.20% compared to 2021. XBIT's yearly revenue for 2021 was $18.39M, representing a decrease of -58.19% compared to 2020.

What is XBiotech’s quarterly revenue?

XBiotech's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). XBIT's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is XBiotech’s revenue growth rate?

XBiotech's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.

What are XBiotech’s revenue streams?

XBiotech's revenue streams in c 22 are Manufacturing Revenue

What is XBiotech’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of XBiotech was Manufacturing Revenue. This segment made a revenue of $4.01M, representing 100.00% of the company's total revenue.